The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Lundbeck’s asedebart, a designation that may…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
A study tied high cortisol in Cushing’s disease to an increase in certain blood cells not explained by the…
Long-term use of corticosteroids may cause iatrogenic Cushing’s syndrome, a side effect of the medication that can…
Although rare, researchers say that recurrent Cushing’s disease can be caused by tumor cells accidentally left in the sphenoid…
Mutations in the USP8 gene appear to switch on a signaling pathway, called Sonic Hedgehog (SHH), in pituitary tumors that…
After an unrelated medical exam revealed a mass on a man’s right adrenal gland, further testing showed his symptoms were…
A father and daughter who carried the same genetic variant both developed Cushing’s disease, according to a recent report.
After surgery for Cushing’s disease, very low levels of cortisol in the morning strongly predict that a patient will…
An artificial intelligence (AI)-designed small molecule that targets the NR3C1 gene may offer a safer, more effective treatment for Cushing’s…
April is Cushing’s Awareness Month, a global effort during which advocacy groups — such as the Cushing’s Support &…